ROVI updates its strategy in a meeting with shareholders, investors and analysts
Mar, 16/11/2021 - 14:31
1 minROVI updates its strategy in a meeting with shareholders, investors and analysts
Relacionados
La liberación sostenida de fármacos es un campo en el que se están logrando importantes avances que permiten aumentar la eficacia de los...
4 min
24/11/2022
A LA COMISIÓN NACIONAL DEL MERCADO DE VALORES
Madrid, 23 de noviembre de 2022
Laboratorios Farmacéuticos ROVI, S.A. (ROVI), en...
1 min
23/11/2022
Título del proyecto: Mejora de la eficiencia energética del proceso de producción de productos farmacéuticos de la planta de Granada....
1 min
17/11/2022
shutterstock_1323088832.jpg
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION
(COMISIÓN NACIONAL DEL MERCADO DE VALORES)
Madrid, 16 November 2021
In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold a virtual meeting today with analysts and investors to present said presentation.
Mr. Juan López-Belmonte Encina
Chairman and Chief Executive Officer
Laboratorios Farmacéuticos ROVI, S.A.